Digestive and Intestinal Remedies Market Report 2025

The digestive and intestinal remedies market size has grown strongly in recent years. It will grow from $21.37 billion in 2024 to $22.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to traditional remedies, lifestyle changes, increased stress levels, dietary shifts, and COVID-19 impact.

The digestive and intestinal remedies market size is expected to see strong growth in the next few years. It will grow to $29.16 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to healthcare accessibility, global health events, rising health consciousness, ageing population, innovative product development. Major trends in the forecast period include healthcare access, environmental factors, consumer education, regulatory environment, pharmaceutical advancements.

The rising number of gastrointestinal disorder cases is anticipated to drive the growth of the digestive and intestinal remedy market in the coming years. Gastrointestinal disorders encompass a range of diseases, including nausea, vomiting, food poisoning, and diarrhea, which affect the overall biological functioning of the gastrointestinal (GI) tract. The increasing prevalence of these disorders has led to a heightened demand for digestive and intestinal remedies capable of effectively treating gastrointestinal diseases. For example, in January 2024, the American Cancer Society, a US-based non-profit organization, projected that around 26,890 new cases of stomach cancer would occur in the U.S. in 2024, with 16,160 cases in men and 10,730 in women. Additionally, this type of cancer is expected to result in approximately 10,880 deaths, including 6,490 men and 4,390 women. Consequently, the growing incidence of gastrointestinal disorders is expected to boost the growth of the digestive and intestinal remedy market.

The expansion of telemedicine services is expected to enhance the growth of the digestive and intestinal remedy market in the future. Telemedicine services involve the remote delivery of healthcare, medical consultations, and clinical services through telecommunications technology, primarily utilizing the Internet and video conferencing tools. The increased accessibility of telemedicine services not only allows individuals with digestive and intestinal issues to conveniently access healthcare for consultations and advice without the need for physical visits but also encourages early intervention and management of disorders, thereby boosting the demand for relevant remedies and medications. For example, in October 2022, a report from the Centers for Disease Control and Prevention, a US-based government agency, indicated that 37% of adults had used telemedicine services in the past 12 months. Women (42%) were notably more likely to utilize telemedicine compared to men (31.7%). Additionally, there was a positive correlation between age and telemedicine usage, with a rise in the percentage of adults engaging in telemedicine as they aged. Specifically, usage rates climbed from 29.4% among adults aged 18-29 to 43.3% among those aged 65 and older. Thus, the growth of telemedicine services is driving the expansion of the digestive and intestinal remedy market.

Technological advancements and developments are significant trends gaining traction in the digestive and intestinal remedy market. Major companies in this sector are concentrating on creating innovative technologies to manage and monitor digestive health. Recently, the market has seen the introduction of breath analyzers that collect clinical information related to the digestive system. For example, in February 2022, FoodMarble, an Ireland-based company that provides breath testing devices, launched the AIRE 2 digestive breath tester. This pocket-sized device enables individuals with digestive issues such as SIBO (Small Intestinal Bacterial Overgrowth) and IBS (Irritable Bowel Syndrome) to measure and monitor their digestion in real time, thereby helping them manage their health more effectively. This cutting-edge technology identifies foods that lead to rapid fermentation in the gut, which can trigger various digestive symptoms. Additionally, the device is designed for use by healthcare professionals to gain deeper insights into patients' digestive disorders, including IBS and SIBO.

Major companies in the digestive and intestinal remedy market are focusing on developing innovative products, including digital platforms, to reach larger customer bases, boost sales, and increase revenue. Digital platforms are online technology-based systems or frameworks that facilitate the creation, delivery, and interaction of digital content, services, or products. For example, in April 2023, Owlstone Medical, a UK-based biotechnology company, launched OMED Health to help patients understand their gut microbiome and effectively manage their digestive health. Initially focusing on digestive disorders, OMED Health aims to enhance the quality of life for individuals dealing with gut health issues by providing improved and expedited insights and control over their conditions. In the realm of digestive health, breath testing is emerging as an effective method for patients to monitor and manage symptoms. A unique feature of OMED Health's gut health tests is their capability to detect minute amounts of hydrogen and methane gases in breath, which allows for a convenient at-home collection process. These gases are critical indicators of gut health, signaling specific conditions and diseases.

In November 2022, Biocodex Group, a healthcare company based in France, successfully acquired Hilma for an undisclosed amount. This strategic acquisition is anticipated to enable Hilma to rapidly expand its omnichannel retail strategy, access new demographics, and foster innovation in product development. The decision to sell by Hilma was driven by the extensive global scale offered by Biocodex, a valuable asset in overcoming the challenges associated with growing a digitally-native brand in the current business landscape. These challenges include managing heightened marketing expenses, addressing logistical complexities, and recruiting specialists for wholesale account expansion. Hilma, the acquired company, is a US-based provider specializing in natural remedies. The acquisition reflects Biocodex's commitment to strengthening its position in the healthcare market and leveraging its global presence for the benefit of Hilma's growth and development.

Major companies operating in the digestive and intestinal remedies market are Bayer AG, Abbott Laboratories, Bausch Health Companies Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Jiangzhong Pharmaceutical Co. Ltd., Johnson & Johnson Pvt. Ltd., Menarini Group, Merck Co. & KGaA, Pfizer Inc., Prestige Consumer Healthcare Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited, AbbVie Inc., Alfa Wassermann and Sigma-Tau, Allergan PLC, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Chemical Pharma Co. Ltd., Evoke Pharma Inc., Ipsen SA, Ironwood Pharmaceuticals Inc., Mundipharma, Mylan NV, Norgine Pharmaceuticals Ltd., Novartis AG, Otsuka Pharmaceutical Co. Ltd., Perrigo Company, Recordati S.p.A., RedHill Biopharma Ltd., Ritter Pharmaceuticals Inc., Salix Pharmaceuticals Inc.

North America was the largest region in the digestive and intestinal remedies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digestive and intestinal remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the digestive and intestinal remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Digestive and intestinal remedies encompass medications designed to address gastrointestinal disorders, including issues like stomach upset, constipation, and diarrhea. The treatment process often involves the use of drug classes such as antacids, proton pump inhibitors, and histamine2 blockers.

The main types of digestive and intestinal remedies include digestive medicines, remedies targeting gastrointestinal complaints, and both natural and synthetic agents. Digestive medicines include compounds like digestive enzymes, which aid the body in breaking down and digesting meals. These medicines are particularly helpful in treating occasional heartburn, nausea, and upset stomach. They cater to various age groups, including pediatric and adult populations, and are distributed through various channels, such as online and offline platforms.

The digestive and intestinal remedies market research report is one of a series of new reports that provides digestive and intestinal remedies market statistics, including digestive and intestinal remedies industry global market size, regional shares, competitors with a digestive and intestinal remedies market share, detailed digestive and intestinal remedies market segments, market trends and opportunities, and any further data you may need to thrive in the digestive and intestinal remedies industry. This digestive and intestinal remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digestive and intestinal remedies market consists of sales of antacids, prokinetic agents, laxatives, antidiarrheal agents, generic enzymes. Values in this market are ''''factory gate'''' values that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.